Multinational Point Prevalence Study on the Management of Diabesity in Hospitals
NCT ID: NCT06680674
Last Updated: 2025-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
400 participants
OBSERVATIONAL
2024-11-13
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
However, the pharmacological treatment of diabesity has made significant progress in recent years.
The objective of this study is to assess the management of diabesity in the international hospital setting. Aims include:
1. to determine the prevalence of causes and duration of hospitalization
2. to investigate the treatments used
3. to determine individual metabolic control achived This is a cross-sectional multi-centre study in which researchers will conduct a one-day point prevalence assessment in internal medicine wards.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Understand the Distribution of Obesity Classes and Obesity Related Diseases in People With Obesity Across Countries in Czech Republic, Hungary and Poland
NCT05795166
Prevalence of Metabolic Syndrome in Atahualpa
NCT01770054
Health Indicators and Patient Reported Outcomes. Identification of Significative Items Aimed at Improving Health Care Procceses.
NCT05343962
Fertility and Cardiovascular Risk in Men With Metabolic Syndrome
NCT03977064
Observational Study of Early Metabolic and Vascular Changes in Obesity
NCT00482924
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Routine care for people with diabetes, with or without obesity, in the hospital setting
Routine care for people with diabetes, with or without obesity, in the hospital setting, including routine pharmacological treatment for diabetes and obesity.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diabetes diagnosis (Known / documented in medical history or newly diagnosed using ADA diagnostic criteria)
* Age ≥ 18 years
* Written informed consent
Exclusion Criteria
* Paediatric patients (Age \< 18 years)
* Patients without a diabetes diagnosis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Cascais Dr. José de Almeida (Portugal)
UNKNOWN
Centre Hospitalier Universitaire Sétif, Service Médecine Interne (Algeria)
UNKNOWN
Rabin Medical Center
OTHER
Hospital Regional de Malaga
OTHER
Charles University, Czech Republic
OTHER
University Hospital Bratislava
OTHER
Complejo Hospitalario de Especialidades Juan Ramón Jimenez
UNKNOWN
Medical University Innsbruck
OTHER
Aristotle University Of Thessaloniki
OTHER
Rostov State Medical University
UNKNOWN
Hospital Marina Baixa
UNKNOWN
Riga East Clinical University Hospital
OTHER_GOV
University Hospital, Aachen
OTHER
San Raffaele University Hospital, Italy
OTHER
Kanuni Sultan Suleyman Training and Research Hospital
OTHER
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ann-Kristin Porth
Research Assistant (PhD)
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandra Kautzky-Willer, Prof
Role: STUDY_DIRECTOR
Medical University of Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna
Vienna, , Austria
General University Hospital in Prague
Prague, , Czechia
University Hospital RWTH Aachen
Aachen, , Germany
Hippokration General Hospital, Aristotle University of Thessaloniki
Thessaloniki, , Greece
Rabin Medical Center, Hasharon Hospital
Petah Tikva, , Israel
Riga East Clinical University Hospital
Riga, , Latvia
Rostov State Medical University
Rostov-on-Don, , Russia
Kanuni Sultan Suleyman Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EK 1828/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.